Dengue numbers in Sri Lanka triple in first quarter of 2012

dengue-numbers-in-sri-lanka-triple-in-first-quarter-of-2012

Sri Lankan health personnel have reported a three-fold increase in the number of recorded dengue fever cases in the first quarter of this year. The Epidemiology Unit said 9,317 dengue cases and 38 deaths were reported in the first three months of 2012, against 3,103 in the first quarter of 2011. The highest number occurred in January, when 3,892 cases were reported, followed by 3,004 in February and 2,421 in March. Local media reported that over 50 percent of dengue cases occurred in the country’s Western Province, where most of the island’s 20 million inhabitants live.

Containers or hollows where stagnant water can accumulate provide breeding grounds for mosquitoes, promoting the spread of dengue. Due to intermittent rains, the breeding continues. Sri Lanka’s meteorological department forecasts that intermittent rains are likely to continue until late April. Heavy rainfall usually occurs during the southwest monsoon (May to September) and during the northeast monsoon (September to January).

According to the World Health Organization (WHO), dengue is the most common mosquito-borne viral disease in humans. Some 2.5 billion people – two-fifths of the world’s population – are at risk from dengue fever, with an estimated 50 million infections worldwide every year. Sri Lanka is classified as a “Category A” country by WHO, which means dengue fever is a leading cause of hospitalization and death among children; there are cyclical epidemics in urban areas; and the virus is a major public health concern.

Three other countries in Southeast Asia share this classification: Thailand, Indonesia and Timor-Leste.

Dengue fever

Dengue fever also known as breakbone fever, is an infectious tropical disease caused by the dengue virus. Symptoms include fever, headache, muscle and joint pains, and a characteristic skin rash that is similar to measles. In a small proportion of cases the disease develops into the life-threatening dengue hemorrhagic fever, resulting in bleeding, low levels of blood platelets and blood plasma leakage, or into dengue shock syndrome, where dangerously low blood pressure occurs.

Dengue is transmitted by several species of mosquito within the genus Aedes, principally A. aegypti. The virus has four different types; infection with one type usually gives lifelong immunity to that type, but only short-term immunity to the others. Subsequent infection with a different type increases the risk of severe complications. As there is no vaccine, prevention is sought by reducing the habitat and the number of mosquitoes and limiting exposure to bites.

Treatment of acute dengue is supportive, using either oral or intravenous rehydration for mild or moderate disease, and intravenous fluids and blood transfusion for more severe cases. The incidence of dengue fever has increased dramatically since the 1960s, with around 50–100 million people infected yearly. Early descriptions of the condition date from 1779, and its viral cause and the transmission were elucidated in the early 20th century. Dengue has become a global problem since the Second World War and is endemic in more than 110 countries. Apart from eliminating the mosquitoes, work is ongoing on a vaccine, as well as medication targeted directly at the virus.

Typically, people infected with dengue virus are asymptomatic (80%) or only have mild symptoms such as an uncomplicated fever. Others have more severe illness (5%), and in a small proportion it is life-threatening. The incubation period (time between exposure and onset of symptoms) ranges from 3–14 days, but most often it is 4–7 days. Therefore, travelers returning from endemic areas are unlikely to have dengue if fever or other symptoms start more than 14 days after arriving home. Children often experience symptoms similar to those of the common cold and gastroenteritis (vomiting and diarrhea), but are more susceptible to the severe complications. 

Sources: IRIN, WHO, Wikipedia

Featured image: Stegomyia aegypti (formerly Aedes aegypti) mosquito biting a human. (Credit: USDA)

If you value what we do here, create your ad-free account and support our journalism.

Share:


Your support makes a difference

Dear valued reader,

We hope that our website has been a valuable resource for you.

The reality is that it takes a lot of time, effort, and resources to maintain and grow this website. We rely on the support of readers like you to keep providing high-quality content.

If you have found our website to be helpful, please consider making a contribution to help us continue to bring you the information you need. Your support means the world to us and helps us to keep doing what we love.

Support us by choosing your support level – Silver, Gold or Platinum. Other support options include Patreon pledges and sending us a one-off payment using PayPal.

Thank you for your consideration. Your support is greatly appreciated.

Sincerely,
Teo Blašković

$5 /month

  • Ad-free account
  • Clean user interface and fast browsing
  • Direct communication with us via chat and email
  • Suggest new features, content and applications
  • Early access to new apps and features

$50 /year

$10 /month

  • Ad-free account
  • Clean user interface and fast browsing
  • Direct communication with us via chat and email
  • Suggest new features, content and applications
  • Early access to new apps and features

$100 /year

$25 /month

  • Ad-free account
  • Clean user interface and fast browsing
  • Direct communication with us via chat and email
  • Suggest new features, content and applications
  • Early access to new apps and features

$200 /year

You can also support us on Patreon

support us on patreon

or by sending us a one-off payment using PayPal:


Commenting rules and guidelines

We value the thoughts and opinions of our readers and welcome healthy discussions on our website. In order to maintain a respectful and positive community, we ask that all commenters follow these rules:

  • Treat others with kindness and respect.
  • Stay on topic and contribute to the conversation in a meaningful way.
  • Do not use abusive or hateful language.
  • Do not spam or promote unrelated products or services.
  • Do not post any personal information or content that is illegal, obscene, or otherwise inappropriate.

We reserve the right to remove any comments that violate these rules. By commenting on our website, you agree to abide by these guidelines. Thank you for helping to create a positive and welcoming environment for all.

Leave a reply

Your email address will not be published. Required fields are marked *